Guardion Health Sciences, Inc.
GHSI
OTC PK
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 6.09M | 6.09M | 6.11M | 5.85M | 5.17M |
| Total Other Revenue | 421.80K | 421.80K | 434.90K | 485.10K | 485.10K |
| Total Revenue | 6.43M | 6.43M | 6.45M | 6.24M | 5.56M |
| Cost of Revenue | 3.54M | 3.59M | 3.62M | 3.82M | 3.52M |
| Gross Profit | 2.88M | 2.84M | 2.83M | 2.42M | 2.04M |
| SG&A Expenses | 7.10M | 7.11M | 7.41M | 7.56M | 8.09M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.66M | 10.72M | 11.04M | 11.43M | 11.71M |
| Operating Income | -4.23M | -4.28M | -4.60M | -5.19M | -6.15M |
| Income Before Tax | -5.93M | -5.38M | -497.00K | -13.38M | -14.57M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -5.93 | -5.38 | -0.50 | -13.38 | -14.57 |
| Earnings from Discontinued Operations | 12.30M | 255.20K | 654.90K | 654.90K | 654.90K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 6.37M | -5.12M | 158.00K | -12.72M | -13.92M |
| EBIT | -4.23M | -4.28M | -4.60M | -5.19M | -6.15M |
| EBITDA | -4.21M | -4.26M | -4.58M | -4.87M | -5.52M |
| EPS Basic | 4.96 | -4.00 | 0.12 | -11.08 | -12.04 |
| Normalized Basic EPS | -2.75 | -2.50 | -0.11 | -1.67 | -2.26 |
| EPS Diluted | 4.96 | -4.01 | 0.12 | -11.10 | -12.06 |
| Normalized Diluted EPS | -2.75 | -2.50 | -0.11 | -1.67 | -2.26 |
| Average Basic Shares Outstanding | 5.10M | 5.08M | 5.07M | 5.04M | 5.00M |
| Average Diluted Shares Outstanding | 5.10M | 5.09M | 5.07M | 5.04M | 5.00M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
